<DOC>
	<DOCNO>NCT00070993</DOCNO>
	<brief_summary>Creatine naturally occur chemical involve production energy muscle . Abnormalities creatine link progression degenerative neuromuscular disease amyotrophic lateral sclerosis ( ALS , Lou Gehrig 's Disease ) . This study test whether take creatine improve symptom ALS .</brief_summary>
	<brief_title>Creatine Treatment Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Amyotrophic lateral sclerosis progressive neurodegenerative disorder selectively affect motor neuron , result progressive weakness . Currently know cure specific cause identify . Creatine nutritional supplement improve mitochondrial function show protect motor neuron animal model ALS . Preliminary research indicate creatine may also improve strength patient ALS . This study determine effect creatine treatment short-term muscle strength long-term muscle deterioration patient ALS . Participants study randomly assign receive either creatine placebo . Participants enrol study 9 month . Quantitative muscle test do weekly first 3 week ; participant follow monthly next 4 month bimonthly remainder 9-month study . The study also monitor purposeful exercise determine enhance benefit creatine usage muscle strength . Pulmonary function test accompany muscle test determine creatine strengthen respiratory muscle , thereby enhance pulmonary function .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Inclusion Criteria Diagnosis probable definite ALS At least 5 10 testable upper extremity muscle group ( shoulder elbow extensors/flexors grip ) Medical Research Council ( MRC ) grade 4 good At least 5 year onset symptom Exclusion Criteria Requires tracheostomy ventilation History renal disease</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>ALS</keyword>
	<keyword>Creatine</keyword>
</DOC>